Medicaid Reimbursement of Primary Care Providers for Treatment of Substance use Disorders

American Medical Association. 1995. A new definition of primary care. JAMA, 273 (3): 192

Fleming MF , Mundt MP , French MT , Manwell LB , Stauffacher EA and Barry KL . 2000. Benefit–cost analysis of brief physician advice with problem drinkers in primary care settings. Med Care, 38 (1): 7–18.

January 2000. Healthy People 2010, January, Washington DC: US Department of Health and Human Services. Available at www.health.gov/healthypeople/.

Fox K , Merrill JC , Chang H and Califano JA Jr. 1995. Estimating the costs of substance abuse to the Medicaid hospital care program. Am J Public Health, 85 (1): 48–54.

Harwood H , Fountain D and Livermore G . 1998. The Economic Costs of Alcohol and Drug Abuse in the United States, 1992, Washington, DC: National Institute on Drug Abuse. NIH publication 98–4327

Frank RG , Huskamp HA , McGuire TG and Newhouse JP . 1996. Some economics of mental health ‘carve–outs’. Arch Gen Psychiatry, 53 (10): 933–937.

Office of Applied Studies. 1998. “Substance Abuse and Mental Health Services Administration”.Uniform Facility Data Set Survey. Available at: www: http://dasis3.samhsa.gov/98ufds/table_3_8.htm.

Gerstein DR and Harwood HJ . 1990. Treating Drug Problems: A Study of the Evolution, Effectiveness, and Financing of Public and Private Drug Treatment Systems, Vol 1, Washington, DC: National Academy Press.

Hanson KW . 1888. Public opinion and the mental health parity debate: lessons from the survey literature. Psychiatr Serv, 49 (8): 1059–1066.

June 7 1999. “Mental Health and Substance Abuse Parity in the Federal Employee Health Benefits Program”. June 7, Washington, DC: Office of Personnel Management. Available at: http://www.opm.gov/insure/health/parity/index.htm.

Mark TL , Coffey RM , King E , Harwood H , McKusick D , Genuardi J , Dilonardo J and Buck JA . 2000. Spending on mental health and substance abuse treatment, 1987–1997. Health Aff (Millwood), 19 (4): 108–120.

McCaffrey B and Office of National Drug Control Policy. 2001. “Accomplishments and Significant Actions, January 1993–January 2001”. Washington, DC: Office of National Drug Control Policy.

Welch WP . 1988. HMO enrollment and Medicaid. Survival analysis with a Weibull function. Med Care, 26 (1): 45–52.

Haack MR . 1998. Treating acute withdrawal from alcohol and other drugs. NUTS Clin North Am., 33 (1): 75–92.

Miller WR . 1983. Motivational interviewing with problem drinkers. BehavPsychother, 11: 147–172.

Annis A . 1991. A cognitive–social learning approach to relapse: phar–macotherapy and relapse prevention counseling. J Alcohol Stud, 1 (suppl): 527–530.

Marlatt GA and Gordon JR . 1985. Relapse Prevention, New York: Guilford Press.

Kumpfer KL , Olds D , Alexander JF , Zucker RA and Gary LE . “Family etiology of youth problems”. In Family–Focused Prevention of Drug Abuse: Research and Interventions, National Institute on Drug Abuse Research Monograph Edited by: Ashery R and Kumpfer KL . Rockville, Md.: National Institute on Drug Abuse. In press

Kumpfer KL , Molgaard V and Spoth R . 1996. “The Strengthening Families Program for prevention of delinquency and drug use in special populations”. In Childhood Disorders, Substance Abuse, and Delinquency: Prevention and Early Intervention Approaches, Edited by: Peters R and McMahon RK . Newbury Park, Calif.: Sage Publications.

Hsiao WC , Braun P , Dunn DL , Becker ER , Yntema D , Verrilli DK , Stamenovic E and Chen SP . 1992. An overview of the development and refinement of the Resource–Based Relative Value Scale. The foundation for reform of US physician payment. Med Care, 30 (11, suppl) NS 1–12

Conviser R , Gamliel S and Honberg L . 1998. Health–based payment for HIV/AIDS in Medicaid managed care programs. Health Care Financ Rev, 19 (3): 63–82.